Sunil Mehta

Sunil Mehta is an experienced leader in the pharmaceutical industry, currently serving as Vice President, Global Medical Affairs TA Head for Rare Disease at Amgen since September 2025. Prior to this role, Sunil held senior positions at Annexon Biosciences and argenx, significantly contributing to medical affairs strategies and the management of medical science liaison teams. Sunil's extensive background includes a notable tenure at Alexion Pharmaceuticals, where responsibilities ranged from Executive Director to Senior Director, overseeing neurology-focused teams and initiatives in the US market. Sunil has a Doctor of Pharmacy (PharmD) from Rutgers University and has developed expertise in recruiting and managing talent, engaging with key opinion leaders (KOLs), and implementing strategic medical affair plans across multiple therapeutic areas, including neurology and hematology.